Susquehanna International Group, LLP Durect Corp Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.64 $53,806 - $90,621	141,596 Added 1242.94%	152,988 $73,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.98 $26,902 - $47,934	-48,913 Reduced 81.11%	11,392 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.9 - $1.31 $17,006 - $24,753	18,896 Added 45.63%	60,305 $59,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.61 $68,564 - $91,230	-56,665 Reduced 57.78%	41,409 $53,000
Q2 2021 Aug 11, 2021	SELL	$1.6 - $2.02 $131,316 - $165,787	-82,073 Reduced 45.56%	98,074 $160,000
Q1 2021 May 17, 2021	BUY	$1.86 - $2.87 $224,751 - $346,793	120,834 Added 203.72%	180,147 $357,000
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $42,099 - $62,001	25,515 Added 75.49%	59,313 $123,000
Q3 2020 Nov 16, 2020	BUY	$1.6 - $2.35 $30,036 - $44,116	18,773 Added 124.95%	33,798 $58,000
Q2 2020 Aug 14, 2020	SELL	$1.33 - $2.76 $2.02 Million - $4.19 Million	-1,518,019 Reduced 99.02%	15,025 $35,000
Q1 2020 May 15, 2020	BUY	$0.97 - $2.85 $715,953 - $2.1 Million	738,096 Added 92.85%	1,533,044 $2.38 Million
Q4 2019 Feb 14, 2020	BUY	$1.69 - $3.8 $1.24 Million - $2.8 Million	735,918 Added 1246.68%	794,948 $3.02 Million
Q3 2019 Nov 14, 2019	BUY	$0.61 - $2.21 $18,849 - $68,291	30,901 Added 109.85%	59,030 $109,000
Q2 2019 Aug 16, 2019	BUY	$0.51 - $0.86 $2,373 - $4,001	4,653 Added 19.82%	28,129 $18,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $19,412 - $32,735	-38,064 Reduced 61.85%	23,476 $15,000
Q4 2018 Feb 14, 2019	BUY	$0.48 - $1.1 $6,626 - $15,185	13,805 Added 28.92%	61,540 $30,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $770 - $1,239	494 Added 1.05%	47,735 $74,000
Q4 2017 Feb 14, 2018	BUY	$0.78 - $2.1 $36,847 - $99,206	47,241	47,241 $43,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account